Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Company: RLAY Minimum: $1M

Company

Date

Insider

Role

Action ?

Shares

Amount

Of holding

RLAY Relay Therapeutics, Inc.

25 Aug 2026

SVF Pauling (Cayman) Ltd

10% owner indirect

Sold at will

6,000,000

$116.40M

21.5%

RLAY Relay Therapeutics, Inc.

22 Jun 2026

Catinazzo Thomas

Chief Financial Officer

Sold on a plan 4×

187,163

$3.18M

51.3%

RLAY Relay Therapeutics, Inc.

22 Jun 2026

Bergstrom Donald A

President, R&D

Sold on a plan

93,456

$1.58M

18.3%

RLAY Relay Therapeutics, Inc.

15 Oct 2021

Bergstrom Donald A

See Remarks

Sold, plan not stated

30,000

$1.02M

39.7%

RLAY Relay Therapeutics, Inc.

16 Jun 2021

Bergstrom Donald A

See Remarks

Sold, plan not stated

42,242

$1.43M

35.4%

RLAY Relay Therapeutics, Inc.

16 Apr 2021

Bergstrom Donald A

See Remarks

Sold, plan not stated

56,324

$1.82M

42.2%

RLAY Relay Therapeutics, Inc.

14 Jan 2021

Third Rock Ventures III, L.P.

10% owner indirect

Sold, plan not stated

1,965,294

$80.58M

100%

RLAY Relay Therapeutics, Inc.

13 Jan 2021

Third Rock Ventures III, L.P.

10% owner

Sold, plan not stated 5×

1,311,197

$52.61M

14.5%

RLAY Relay Therapeutics, Inc.

13 Jan 2021

Third Rock Ventures III, L.P.

10% owner indirect

Sold, plan not stated 5×

845,903

$33.94M

30.1%

RLAY Relay Therapeutics, Inc.

12 Jan 2021

Third Rock Ventures III, L.P.

10% owner

Sold, plan not stated

1,500,000

$60.00M

14.2%

Showing 1–10 of 10.